The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer

Abstract

網羅的なHLAリガンドーム解析により,がん幹細胞(cancer stem cell,CSC)に特異的なASB4由来のペプチドIV9を同定し,CSCを特異的に傷害可能なCTL免疫療法となることを示した.更にCSCを標的としたCTL免疫療法が再発予防として有用であることを明らかにした

Similar works

Full text

thumbnail-image

sapporo medical university Information and KnOwledge Repository)

redirect
Last time updated on 20/03/2019

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.